- $78.70m
- $74.10m
- $16.28m
- 63
- 59
- 52
- 58
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | 6-K |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 10.5 | 10.9 | 11.2 | 13.3 | 13.9 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 10.5 | 9.72 | 11.5 | 13.3 | 13.9 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 2.29 | 3.43 | 3.67 | 4.57 | 4.35 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.92 | 2.81 | 3 | 3.71 | 3.54 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.92 | 2.81 | 3 | 3.71 | 3.54 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.92 | 2.81 | 3 | 3.71 | 3.54 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.58 | 2.32 | 2.48 | 3.07 | 2.92 |
Dividends per Share |